Sign in
4

Changes in Ownership

Xeris Biopharma Holdings, Inc. Filed Acc 0001635065-26-000002

Director sold 16,000 shares at $6.09 ($97,507)

  • Director acquired 24,193 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BORMANN-KENNEDY BARBARA-JEAN ANNE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-04 Sale : show line 1 in the form 10b5-1 −16,000 $6.09 $97,507 126,500 D
2026-06-04 Grant or award : show line 2 in the form 10b5-1 +24,193 150,693 D
Open-market sales · 16,000 sh · avg $6.09 · $97,507

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-04 Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) +32,996 $6.15 $202,925 32,996 D
Loading xslF345X06/wk-form4_1780697885.xml…